COffee and Metabolites Modulating the Gut MicrobiomE in coloN canCER
Conditions: Colorectal Cancer; Coffee; Gastrointestinal Microbiome; Stenosis; Fibrosis, Liver; Ultrasound Elastography; Proton Magnetic Resonance Spectroscopy Interventions: Drug: Nestlé NESCAFÉ® TASTER'S CHOICE® House Blend capsule.; Drug: Placebo Sponsors: Massachusetts General Hospital; National Institutes of Health (NIH) Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Cancer | Cancer & Oncology | Coffee | Colon Cancer | Colorectal Cancer | Gastroenterology | Hospitals | Liver | Research | Ultrasound | Urology & Nephrology